The target of miR-26a is Enhancer of Zeste Homolog 2 (EZH2), the catalytic subunit of the Polycomb Repressive Complex that is involved in EMT and is best known to repress a large number of tumor suppressor genes. Here, EZH2 is linked to neoplasm.